← Live StudiesRegistry: recruitingPhase 3

ENLIGHTEN-1: Eloralintide for obesity without type 2 diabetes

Compares once-weekly investigational eloralintide with placebo in adults with obesity or overweight who do not have type 2 diabetes.

Who it's for

  • Age 18+
  • BMI ≥30, or ≥27 plus a weight-related condition
  • People with type 2 diabetes excluded

Full eligibility rules apply. The study team decides who can take part.

Where it runs

9 research locations in Arizona, California and Hawaii.

Arizona

  • Headlands Research - ScottsdaleScottsdale, AZ

California

  • Neighborhood Healthcare Institute of HealthEscondido, CA
  • Ark Clinical Research - Fountain ValleyFountain Valley, CA
  • Desert Oasis Healthcare Medical GroupPalm Springs, CA
  • Peninsula Research AssociatesRolling Hills Estates, CA
  • Care Access - SacramentoSacramento, CA
  • Southern California Clinical ResearchSanta Ana, CA
  • University Clinical Investigators, Inc.Tustin, CA

Hawaii

  • East-West Medical Research InstituteHonolulu, HI

Site recruitment may change. The official record lists every location, including outside these states.

Interested in this study?

Ask us about it, or refer a patient. Taking part is voluntary, and the study team decides who can join.